Corcept Therapeutics Inc (NAS:CORT)
$ 27.04 0.44 (1.65%) Market Cap: 2.82 Bil Enterprise Value: 2.40 Bil PE Ratio: 25.51 PB Ratio: 5.13 GF Score: 93/100

Preliminary Q4 2020 Corcept Therapeutics Inc Earnings Call and Corporate Update Transcript

Feb 08, 2021 / 10:00PM GMT
Release Date Price: $30.56 (+3.91%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Corcept Therapeutics Conference Call. (Operator Instructions)

I would now like to hand the conference over to your speaker for today, Charlie Robb. You may begin.

Gary Charles Robb
Corcept Therapeutics Incorporated - CFO & Secretary

Good afternoon. My name is Charlie Robb. I'm Corcept's Chief Financial Officer. Today, we issued a press release announcing our fourth quarter and full year preliminary selected financial results and providing a corporate update. A copy is available at corcept.com. Complete results will be available when we file our Form 10-K with the SEC. Today's call is being recorded. A replay will be available at the Investors Past Events tab of our website.

Statements during this call, other than statements of historical fact are forward-looking statements based on our plans and expectations that are subject to risks and uncertainties, which might cause actual results to differ materially from those such statements express or imply. These risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot